Alicja Puszkiel

Development and validation of an ELISA method for the quantification of nivolumab in plasma from non-small-cell lung cancer patients

Alicja Puszkiel, Gaëlle Noé, Pascaline Boudou‐Rouquette et al. · Journal of Pharmaceutical and Biomedical Analysis · 2017 · 42 citations

Medicine, Immunology, Oncology +11

Model‐Based Quantification of Impact of Genetic Polymorphisms and Co‐Medications on Pharmacokinetics of Tamoxifen and Six Metabolites in Breast Cancer

Alicja Puszkiel, Cécile Arellano, Christelle Vachoux et al. · Clinical Pharmacology & Therapeutics · 2020 · 31 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Exposure–Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer

Thomas Rodier, Alicja Puszkiel, Evelina Cardoso et al. · Pharmaceutics · 2022 · 31 citations · Full text

Medicine, Oncology, Pharmacology +17

Population Pharmacokinetics/Pharmacodynamics of Dabrafenib Plus Trametinib in Patients with BRAF-Mutated Metastatic Melanoma

David Balakirouchenane, Sarah Guégan, Chantal Csajka et al. · Cancers · 2020 · 28 citations · Full text

Pharmacy, Oncology, Pharmacokinetics +17

A simple HPLC-UV method for quantification of enzalutamide and its active metabolite N-desmethyl enzalutamide in patients with metastatic castration-resistant prostate cancer

Alicja Puszkiel, Alain Plé, Olivier Huillard et al. · Journal of Chromatography B · 2017 · 27 citations

Medicine, Oncology, Pharmacology +11